Study details
Enrolling now
Breast Re-irradiation After Second Ipsilateral Lumpectomy
Youssef Zeidan
NCT IDNCT06867484ClinicalTrials.gov data as of Apr 2026
Target enrollment
114
Study length
about 7.6 years
Ages
40+
Sex
Female only
Locations
2 sites in FL
About this study
This trial is testing the safety of treating breast cancer with re-radiation after a second surgery on the same side as before. The researchers want to see what effects, both good and bad, re-radiation has on people who have already received radiation treatment before surgery.
Based on ClinicalTrials.gov records.
What participants do
- 1.Receive Intensity modulated radiation therapy (IMRT)
Primary goalRate of grade 3 or higher treatment-related adverse events (AEs)
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low10%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: Rate of grade 3 or higher treatment-related adverse events (AEs)
Secondary: Distant metastasis-free survival (DMFS), Overall survival (OS)
Body systems
Oncology